kaiser glp 1 coverage 2026 📌 Starting January 1, 2025, Permanente will be making adjustments to the of GLP-1 drugs and other Anti-Obesity Medications (AOMs) in California commercial plans. For members with a BMI less How much and why ACA

Huang Z, Liu L, Zhang J, Conde K, Phansalkar J, Li Z, et al

That is not a scare tactic

2023;9(11) doi: 10.1016/j.heliyon.2023.e21233

the provider does not need to be Medicare-enrolled) Receive prior authorization from your Part D plan, which is the standard pre-approval process Medicare uses for covered medications Patients who initiated GLP-1 therapy before the Bridge Program launched can still qualify if they met the BMI criteria at the time therapy was initiated, even if their current BMI is now lower (a common situation for patients who have already achieved meaningful weight loss)

These medications work through multiple complementary mechanisms: they enhance glucose-dependent insulin secretion, suppress inappropriate glucagon release, slow gastric emptying, and reduce appetitecollectively improving glycaemic control whilst minimising the risk of hypoglycaemia